Lanreotide Acetate

Spécifications

127984-74-1Numéro CAS

694-399-4Numéro CE

acetic acid;(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,Nom IUPAC

C56H73N11O12S2Formule chimique

1156.4 g/molMasse molaire

Lanreotide acetate; Somatuline LP; Somatuline Depot; Somatuline Autogel; BIM-23014C; IEU56G3J9C; RefChem:552347; DTXSID201027706; L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide, acetate; 127984-74-1; Lanreotide (acetate); 2378114-72-6; Somatuline; acetic acid;(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide; L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2?7)-disulfide, acetate (salt) (9CI); 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane, cyclic peptide deriv.; BIM 23014C; Lanreotide acetate; Somatulina; Somatuline; MFCD00873576; orb1299003; CHEMBL1201184; SCHEMBL29405684; SCHEMBL29846268; HY-P1959A; ITM-014; BN-52030; CS-0113779; P1088; G12821Synonymes